On November 29, Gelonghui reported that Jiangsu Kanion Pharmaceutical (600557.SH) announced that the National Medical Insurance Administration and the Ministry of Human Resources and Social Security released the notice on the publication of the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalogue (2024)". According to this notice, Jiangsu Kanion Pharmaceutical Co., Ltd. exclusive product Jichuan Decoction Granules has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalogue (2024)" for the first time through negotiations. The company's product Muscle and Bone Pain Relief Gel (exclusive product) and Linggui Zhugan Granules have been adjusted from the negotiation catalogue to the National Medical Insurance regular catalogue; Pirfenidone tablets and Posaconazole enteric-coated tablets are newly approved products for the company in 2023 and 2024, and are included in the regular catalogue of the National Medical Insurance Catalogue; Xiaoyao tablets have been removed from the National Medical Insurance Catalogue. Except for the above adjusted products, other products of the company included in the "National Medical Insurance Catalogue (2024)" remain unchanged from the "National Medical Insurance Catalogue (2023)". Currently, the company has a total of 114 products included in the "National Medical Insurance Catalogue," of which 48 are Class A and 66 are Class B.